Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations

C Ke, KMV Narayan, JCN Chan, P Jha… - Nature Reviews …, 2022 - nature.com
Nearly half of all adults with type 2 diabetes mellitus (T2DM) live in India and China. These
populations have an underlying predisposition to deficient insulin secretion, which has a key …

Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart …

AS Volgman, LS Palaniappan, NT Aggarwal, M Gupta… - Circulation, 2018 - Am Heart Assoc
South Asians (from Bangladesh, Bhutan, India, the Maldives, Nepal, Pakistan, and Sri
Lanka) make up one quarter of the world's population and are one of the fastest-growing …

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020Table. No title available.

R Chawla, SV Madhu, BM Makkar… - Indian journal of …, 2020 - journals.lww.com
Guidelines RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2
Diabetes Mellitus 2020Table. No title available.

Therapeutic potential of quercetin in the management of type-2 diabetes mellitus

P Ansari, ST Choudhury, V Seidel, AB Rahman… - Life, 2022 - mdpi.com
Diabetes Mellitus (DM) is a metabolic disorder that is spreading alarmingly around the
globe. Type-2 DM (T2DM) is characterized by low-grade inflammation and insulin resistance …

Multifactorial basis and therapeutic strategies in metabolism-related diseases

JVS Guerra, MMG Dias, AJVC Brilhante, MF Terra… - Nutrients, 2021 - mdpi.com
Throughout the 20th and 21st centuries, the incidence of non-communicable diseases
(NCDs), also known as chronic diseases, has been increasing worldwide. Changes in …

Current position of gliclazide and sulfonylureas in the contemporary treatment paradigm for type 2 diabetes: a sco** review

I Sahin, O Bakiner, T Demir, R Sari, A Atmaca - Diabetes Therapy, 2024 - Springer
The increasing burden of type 2 diabetes (T2D), in relation to alarming rise in the
prevalence; challenges in the diagnosis, prevention, and treatment; as well as the …

Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus–International Task Force

S Kalra, S Bahendeka, R Sahay, S Ghosh… - Indian journal of …, 2018 - journals.lww.com
For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic
armamentarium. They have been used as monotherapy as well as combination therapy …

Management of type 2 diabetes in develo** countries: balancing optimal glycaemic control and outcomes with affordability and accessibility to treatment

V Mohan, K Khunti, SP Chan, FF Filho, NQ Tran… - Diabetes Therapy, 2020 - Springer
With the growing prevalence of type 2 diabetes, particularly in emerging countries, its
management in the context of available resources should be considered. International …

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents

S Colagiuri, D Matthews, LA Leiter, SP Chan… - Diabetes research and …, 2018 - Elsevier
The sulfonylureas are effective oral glucose-lowering agents with a long history of clinical
use. While all have the same general mechanism of action, their pharmacokinetic properties …

The role of sulfonylureas in the treatment of type 2 diabetes

B Tomlinson, NG Patil, M Fok, P Chan… - Expert Opinion on …, 2022 - Taylor & Francis
ABSTRACT Introduction Type 2 diabetes (T2D) is increasingly prevalent and associated
with increased risk for cardiovascular and renal disease. After lifestyle modification …